deca-durabolin 50mg/1ml solution for injection ampoules
aspen pharma trading ltd - nandrolone decanoate - solution for injection - 50mg/1ml
deca durabolin 50 mg/ml solution for injection (am 50 mg/ml solution for injection
organon laboratories limited - nandrolone decanoate - solution for injection - 50 mg/ml
deca durabolin 50 mg/ml solution for injection (am
organon laboratories limited - nandrolone decanoate - solution for injection - 50 mg/ml
deca-durabolin orgaject
pharmacy retailing (nz) ltd t/a healthcare logistics - nandrolone decanoate 50 mg/ml - solution for injection - 50 mg/ml - active: nandrolone decanoate 50 mg/ml excipient: arachis oil benzyl alcohol - deca-durabolin can be used for the treatment of osteoporosis; for the palliative treatment of selected cases of disseminated mammary carcinoma in women and as an adjunct to specific therapies and dietary measures in pathologic conditions characterized by a negative nitrogen balance.
deca durabolin 100mg/ml, solution for injection (a 100 mg/ml solution for injection
organon laboratories limited - nandrolone decanoate - solution for injection - 100 mg/ml
deca durabolin 50 mg/ml solution for injection
nv organon - nandrolone decanoate - solution for injection - 50 mg/ml
deca durabolin 100mg/ml, solution for injection (a
organon laboratories limited - nandrolone decanoate - solution for injection - 100 mg/ml
deca-durabolin solution for injection 50mg/ml
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - nandrolone decanoate - solution for injection - nandrolone decanoate 50 mg/ml - anabolic agents for systemic use
deca-durabolin 50 mg/ml solution for injection
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for injection - nandrolone decanoate 50 mg/ml - anabolic agents for systemic use
deca-durabolin orgaject 50mg/1ml injection ampoule
aspen pharmacare australia pty ltd - nandrolone decanoate, quantity: 50 mg/ml - injection, solution - excipient ingredients: arachis oil; benzyl alcohol - indications as at 16 april 1997. acute renal failure, chronic renal insufficiency and anaemia of chronic renal failure. for the palliative treatment of inoperable mammary carcinoma. osteoporosis (where oestrogen therapy is contraindicated). aplastic anaemia. patients on long-term treatment with corticosteriods.